Positions

Overview

  • Dr. Keith (Tony) Jones received his Medical Degree from the University of Alabama (UA) School of Medicine in 1986. He completed an anesthesiology residency and postgraduate studies at Mayo Clinic, which included advanced training in Neuroanesthesia and a Postdoctoral NIH Research fellowship. Dr. Jones was a member of the faculty of the Mayo Clinic College of Medicine and practiced in the Department of Anesthesiology at Mayo Clinic for 15 year, and then served as the Alfred Habeeb Professor and Chair of the Department of Anesthesiology and Perioperative Medicine at the University of Alabama at Birmingham (UAB) from July 2006 to October 2017. Dr. Jones is currently the President of the University of Alabama Health Services Foundation and Chief Physician Executive of the UAB Health System. Dr. Jones also serves on the Joint Operating Leadership Council for UAB Medicine and the Executive Cabinet of the UAB Health System, as well as Senior Associate Dean for Clinical Affairs in the UA School of Medicine.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Building information modelling to support maintenance management of healthcare built assets 2019
    2018 A validated low carbon office building intervention model based on structural equation modelling 2018
    2018 The core cyber-defense knowledge, skills, and abilities that cybersecurity students should learn in school: Results from interviews with cybersecurity professionals 2018
    2018 Incidence of venous air embolism during endoscopic retrograde cholangiopancreatography 2018
    2017 Energy-saving occupant behaviours in offices: change strategies 2017
    2017 Built asset management climate change adaptation model 2017
    2017 Gibson and Crooks (1938): Vision and validation 2017
    2017 The effect of implementation of preoperative and postoperative care elements of a perioperative surgical home model on outcomes in patients undergoing hip arthroplasty or knee arthroplasty 2017
    2016 Built environments and ‘direct’ energy consumption - A conceptual methodology framework to facilitate delivery of the climate change act 2008 2016
    2016 Do Tele-Operators Learn to Better Judge Whether a Robot Can Pass Through an Aperture? 2016
    2016 Internet use and cybersecurity concerns of individuals with visual impairments 2016
    2016 Perceptions about the relative importance of patient care-related topics: A single institutional survey of its anesthesiologists, nurse anesthetists, and surgeons 2016
    2015 Asset management using a hybrid backcasting/forecasting approach 2015
    2015 Obsolescence types and the built environment - Definitions and implications 2015
    2015 Perioperative Surgical Home. Perspective II. 2015
    2014 Promoting low-carbon home adaptations and behavioural change in the older community 2014
    2014 The potential for energy reduction in UK commercial offices through effective management and behaviour change 2014
    2014 Barriers towards reducing domestic energy consumption - Findings of a study among social housing tenants 2014
    2014 Environmental management practices and engineering science: a review and typology for future research. 2014
    2014 Risk factors associated with reoperation for bleeding following liver transplantation 2014
    2014 Sustainability of and obsolescence in the built environment: Two contrary notions 2014
    2014 The effects of prism adaptation on egocentric metric distance estimation 2014
    2014 The perioperative surgical home: How anesthesiology can collaboratively achieve and leverage the triple aim in health care 2014
    2013 Halothane binds to druggable sites in the [Ca2+] 4-calmodulin (CaM) complex, but does not inhibit [Ca 2+]4-CaM activation of kinase 2013
    2013 Domestic energy consumption - What role do comfort, habit, and knowledge about the heating system play? 2013
    2013 The Perioperative Surgical Home: How can it make the case so everyone wins? 2013
    2013 Negotiating community resilience in the city in a time of political change and deficit reduction 2013
    2013 Abnormal calcium cycling and cardiac arrhythmias associated with the human Ser96Ala genetic variant of histidine-rich calcium-binding protein 2013
    2013 Assessing vulnerability, resilience and adaptive capacity of a UK Social Landlord 2013
    2012 Environmental sustainability and climate change mitigation-CCS technology, better having it than not having it at all! 2012
    2012 Perceived inefficiency in social housing maintenance 2012
    2011 Advent of Climate Change and Resultant Energy Related Obsolescence in the Built Environment 2011
    2011 Human-Robot Interaction: Toward Usable Personal Service Robots 2011
    2011 Extreme weather events and construction SMEs: Vulnerability, impacts, and responses 2011
    2011 Teleoperation Through Apertures:Passability Versus Driveability 2011
    2010 An investigation of the prevalence of replication research in human factors 2010
    2009 Developing an intelligent sensor for monitoring pipeline-system integrity 2009
    2009 Can metric feedback training hinder actions involving distance? 2009
    2009 MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20 2009
    2009 Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury 2009
    2009 Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity 2009
    2008 Does content affect whether users remember that web pages were hyperlinked? 2008
    2008 Volatile anesthetic binding to proteins is influenced by solvent and aliphatic residues 2008
    2008 Application of integrated wireless sensors in oil pipeline integrity monitoring 2008
    2008 Performance measurement and benchmarking of a major innovation programme 2008
    2007 A new performance-based process model for built asset maintenance 2007
    2007 Monitoring of a strategic partnering process: The Amphion experience 2007
    2007 Operational factors affecting strategic partnering in UK social housing 2007
    2007 Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide 2007
    2007 H2O2-induced kinetic and chemical modifications of smooth muscle myosin: Correlation to effects of H2O2 on airway smooth muscle 2007
    2006 Prolonged relaxation consistent with persistent soluble guanylyl cyclase activation in canine pulmonary artery following brief treatment with nitric oxide donors 2006
    2006 Differential effects of volatile anesthetics on M3 muscarinic receptor coupling to the Gαq heterotrimeric G protein 2006
    2006 Nitric oxide sensitivity in pulmonary artery and airway smooth muscle: A possible role for cGMP responsiveness 2006
    2006 Halothane does not inhibit the functional coupling between the β2-adrenergic receptor and the Gαs heterotrimeric G protein 2006
    2006 Reliability and validity of an assessment of usual phytoestrogen consumption (United States) 2006
    2006 Width guidelines for rectangular objects with penetrable and impenetrable borders 2006
    2006 NO responsiveness in pulmonary artery and airway smooth muscle: The role of cGMP regulation 2006
    2006 Prediction of volatile anesthetic binding sites in proteins 2006
    2006 Retrofitting E-learning to an existing distance learning course: A case study 2006
    2005 Why does the negative impact of inconsistent knowledge on web navigation persist? 2005
    2005 Contrasting effects of puerarin and daidzin on glucose homeostasis in mice 2005
    2005 GUI objects with impenetrable borders: Instruction (not practice) makes perfect 2005
    2005 A report on a novice user's interaction with the Internet through a self-voicing application 2005
    2005 Anesthetics inhibit membrane receptor coupling to the Gq/11 heterotrimeric G protein in airway smooth muscle 2005
    2005 Effect of halothane on Gαi-3 and its coupling to the M2 muscarinic receptor 2005
    2004 On the terminology for describing the length-force relationship and its changes in airway smooth muscle 2004
    2004 Saturation transfer difference nuclear magnetic resonance spectroscopy as a method for screening proteins for anesthetic binding 2004
    2004 Anesthetics inhibit acetylcholine-promoted guanine nucleotide exchange of heterotrimeric G proteins of airway smooth muscle 2004
    2004 The Effects of Hexanol on Gαi Subunits of Heterotrimeric G Proteins 2004
    2003 Loudness adaptation: Fact or artifact? 2003
    2003 Comparing mouse and steady-state visual evoked response-based control 2003
    2003 Profiling and quantification of isoflavonoids in kudzu dietary supplements by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry 2003
    2003 Effect of halothane on the guanosine 5′ triphosphate binding activity of G-protein α i subunits 2003
    2003 Dual effects of hexanol and halothane on the regulation of calcium sensitivity in airway smooth muscle 2003
    2003 A novel mechanism by which hydrogen peroxide decreases calcium sensitivity in airway smooth muscle 2003
    2003 A novel mechanism by which hydrogen peroxide decreases calcium sensitivity in airway smooth muscle. 2003
    2003 What Is an Affordance? 2003
    2002 Factors affecting the usefulness of impenetrable interface element borders 2002
    2002 Differential effects of soluble and particulate guanylyl cyclase on Ca2+ sensitivity in airway smooth muscle 2002
    2002 Effects of primary alcohols on airway smooth muscle 2002
    2002 Fast track anesthesia for liver transplantation reduces postoperative ventilation time but not intensive care unit stay 2002
    2002 Users' schemata of hypermedia: What is so 'spatial' about a website? 2002
    2001 Calcium sensitization produced by G protein activation in airway smooth muscle 2001
    2001 Calcium sensitization produced by G protein activation in airway smooth muscle. 2001
    2001 Halothane increases smooth muscle protein phosphatase in airway smooth muscle 2001
    2001 The effects of ethanol on Ca2+ sensitivity in airway smooth muscle 2001
    2001 Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction 2001
    2000 Identification and characterization of two G protein-coupled receptors for neuropeptide FF. 2000
    2000 Relationship between force and regulatory myosin light chain phosphorylation in airway smooth muscle 2000
    2000 Relationship between force and regulatory myosin light chain phosphorylation in airway smooth muscle. 2000
    2000 Brain-computer interfaces based on the steady-state visual-evoked response 2000
    2000 S-nitrosoglutathione-induced decrease in calcium sensitivity of airway smooth muscle 2000
    2000 S-nitrosoglutathione-induced decrease in calcium sensitivity of airway smooth muscle. 2000
    2000 Effects of intravenous anesthetics on Ca2+ sensitivity in canine tracheal smooth muscle 2000
    2000 The effects of signal salience and caffeine on performance, workload, and stress in an abbreviated vigilance task 2000
    1999 Hydrogen peroxide decreases Ca(2+) sensitivity in airway smooth muscle by inhibiting rMLC phosphorylation. 1999
    1999 Hydrogen peroxide decreases Ca2+sensitivity in airway smooth muscle by inhibiting rMLC phosphorylation. 1999
    1999 Hydrogen peroxide decreases Ca2+ sensitivity in airway smooth muscle by inhibiting rMLC phosphorylation 1999
    1999 F-actin stabilization increases tension cost during contraction of permeabilized airway smooth muscle in dogs 1999
    1999 ATP hydrolysis during contraction of permeabilized airway smooth muscle 1999
    1999 ATP hydrolysis during contraction of permeabilized airway smooth muscle. 1999
    1999 Effect of halothane on intracellular calcium oscillations in porcine tracheal smooth muscle cells 1999
    1999 Effect of halothane on intracellular calcium oscillations in porcine tracheal smooth muscle cells. 1999
    1999 cGMP modulation of Ca2+ sensitivity in airway smooth muscle. 1999
    1999 cGMP modulation of Ca2+sensitivity in airway smooth muscle. 1999
    1999 cGMP modulation of Ca2+ sensitivity in airway smooth muscle 1999
    1998 Evaluation of an electroencephalographic-based control device 1998
    1998 Halothane attenuates calcium sensitization in airway smooth muscle by inhibiting G-proteins 1998
    1998 Drug-specific effects of volatile anesthetics on Ca2+ sensitization in airway smooth muscle 1998
    1998 Cross-bridge cycling kinetics, actomyosin ATPase activity and myosin heavy chain isoforms in skeletal and smooth respiratory muscles 1998
    1998 cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione 1998
    1998 cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione. 1998
    1998 cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione. 1998
    1998 Effect of phorbol esters on Ca2+ sensitivity and myosin light-chain phosphorylation in airway smooth muscle. 1998
    1998 Effect of phorbol esters on Ca2+ sensitivity and myosin light-chain phosphorylation in airway smooth muscle 1998
    1998 Mechanisms of cerebral arterial relaxations to hydrogen peroxide 1998
    1998 The role of cGMP in the relaxation to nitric oxide donors in airway smooth muscle 1998
    1997 Role of protein kinase C in calcium sensitization during muscarinic stimulation in airway smooth muscle 1997
    1997 Halothane attenuation of calcium sensitivity in airway smooth muscle: Mechanisms of action during muscarinic receptor stimulation 1997
    1997 Role of protein kinase C in calcium sensitization during muscarinic stimulation in airway smooth muscle. 1997
    1997 Role of protein kinase C in calcium sensitization during muscarinic stimulation in airway smooth muscle. 1997
    1997 Muscarinic receptor stimulation modulates the effect of halothane on Mn2+ influx in airway smooth muscle. 1997
    1997 Muscarinic receptor stimulation modulates the effect of halothane on Mn2+ influx in airway smooth muscle 1997
    1997 Stereospecific effects of ketamine enantiomers on canine tracheal smooth muscle 1997
    1997 Halothane inhibits agonist-induced potentiation of rMLC phosphorylation in permeabilized airway smooth muscle. 1997
    1997 Halothane inhibits agonist-induced potentiation of rmlc phosphorylation in permeabilized airway smooth muscle 1997
    1997 The effects of halothane pretreatment on manganese influx induced by muscarinic stimulation of airway smooth muscle 1997
    1997 Calcium concentration-dependent mechanisms through which ketamine relaxes canine airway smooth muscle 1997
    1996 Friction in airway smooth muscle: Mechanism, latch, and implications in asthma 1996
    1996 The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer. 1996
    1996 Halothane reduces myofilament Ca2+ sensitivity during muscarinic receptor stimulation of airway smooth muscle. 1996
    1996 Halothane reduces myofilament Ca2+ sensitivity during muscarinic receptor stimulation of airway smooth muscle 1996
    1996 Use of nitric oxide-nucleophile adducts as biological sources of nitric oxide: Effects on airway smooth muscle 1996
    1996 Halothane and potassium channels in airway smooth muscle 1996
    1995 Halothane reduces force and intracellular Ca2+ in airway smooth muscle independently of cyclic nucleotides. 1995
    1995 Halothane reduces force and intracellular Ca2+ in airway smooth muscle independently of cyclic nucleotides 1995
    1994 Effects of halothane on the relationship between cytosolic calcium and force in airway smooth muscle. 1994
    1994 A computer-controlled, closed-loop infusion system for infusing muscle relaxants: Its use during motor-evoked potential monitoring 1994
    1994 Changes in cytosolic cGMP and calcium in airway smooth muscle relaxed by 3-morpholinosydnonimine 1994
    1994 Changes in cytosolic cGMP and calcium in airway smooth muscle relaxed by 3-morpholinosydnonimine 1994
    1994 Changes in cytosolic cGMP and calcium in airway smooth muscle relaxed by 3-morpholinosydnonimine. 1994
    1994 Effects of halothane on the relationship between cytosolic calcium and force in airway smooth muscle 1994
    1994 Effects of halothane on the relationship between cytosolic calcium and force in airway smooth muscle 1994
    1994 Halothane and pertussis toxin-sensitive G proteins in airway smooth muscle 1994
    1993 Severe HELLP syndrome presenting with acute gum bleeding following toothbrushing at 38 weeks' gestation. 1993
    1993 Halothane alters cytosolic calcium transient in tracheal smooth muscle. 1993
    1993 A Versatile, Computer-Controlled, Closed-Loop System for Continuous Infusion of Muscle Relaxants 1993
    1993 Factors influencing the direct actions of volatile anesthetics on airway smooth muscle 1993
    1993 Halothane alters cytosolic calcium transient in tracheal smooth muscle 1993
    1992 Method of intraoperative monitoring of neuromuscular function and residual blockade in the recovery room. 1992

    Chapter

    Year Title Altmetric
    2015 Affordance perception research.  530-546. 2015
    2012 Preparing for Extreme Weather Events: A Risk Assessment Approach.  269-281. 2012

    Research Overview

  • In addition to his many teaching, mentorship and clinical activities, Dr. Jones has been a prolific researcher with interests in airway smooth muscle physiology and pharmacology, and the cellular and biochemical mechanisms by which volatile anesthetics and reactive oxygen species alter smooth muscle function. More recently, his research interests include health services research with an emphasis on models of perioperative care. He has authored or co-authored more than 160 scholarly works. His studies have been supported by research grants from the National Institutes of Health. Dr. Jones also serves as a member of the Board of Directors for the International Anesthesia Research Society.
  • Education And Training

  • Mayo Clinic, Internship 1987
  • Mayo Clinic, Residency 1990
  • Mayo Clinic, Postdoctoral Fellowship 1990
  • Full Name

  • Tony Jones